Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
Figure 4
SgII production outside of the left ventricle in heart failure.
SgII levels were decreased in pulmonary tissue during HF development, while levels were unchanged in the other tissues examined. SgII levels in the (A) right ventricle, (B) pulmonary tissue, (C) liver, (D) spleen, (E) kidney, (F) stomach, (G) colon, and (H) skeletal muscle were measured by RIA and are presented as fold change ± SEM (n = 6 for both groups, except pulmonary tissue: HF: n = 14, sham: n = 13). # p<0.05.